Philip B. Hylemon

2.2k total citations
30 papers, 1.9k citations indexed

About

Philip B. Hylemon is a scholar working on Oncology, Molecular Biology and Epidemiology. According to data from OpenAlex, Philip B. Hylemon has authored 30 papers receiving a total of 1.9k indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Oncology, 16 papers in Molecular Biology and 11 papers in Epidemiology. Recurrent topics in Philip B. Hylemon's work include Drug Transport and Resistance Mechanisms (14 papers), Cell death mechanisms and regulation (7 papers) and Cancer-related Molecular Pathways (6 papers). Philip B. Hylemon is often cited by papers focused on Drug Transport and Resistance Mechanisms (14 papers), Cell death mechanisms and regulation (7 papers) and Cancer-related Molecular Pathways (6 papers). Philip B. Hylemon collaborates with scholars based in United States, United Kingdom and France. Philip B. Hylemon's co-authors include Paul Dent, Steven Grant, Douglas M. Heuman, Reno Z. Vlahcevic, Seema Gupta, Liang Qiao, Elaine Studer, Paul B. Fisher, William M. Pandak and Douglas M. Heuman and has published in prestigious journals such as Journal of Biological Chemistry, Gastroenterology and Molecular and Cellular Biology.

In The Last Decade

Philip B. Hylemon

30 papers receiving 1.9k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Philip B. Hylemon United States 22 949 772 694 591 437 30 1.9k
Mieko Iwahashi United States 19 413 0.4× 506 0.7× 355 0.5× 395 0.7× 221 0.5× 27 1.4k
M Ananthanarayanan United States 16 1.5k 1.6× 484 0.6× 477 0.7× 1.1k 1.8× 254 0.6× 26 2.1k
Mihwa Choi United States 12 1.5k 1.5× 1.9k 2.5× 904 1.3× 1.3k 2.1× 314 0.7× 15 3.7k
Bingning Dong United States 20 546 0.6× 837 1.1× 578 0.8× 514 0.9× 307 0.7× 30 2.0k
Graham P. Hayhurst United Kingdom 16 497 0.5× 846 1.1× 495 0.7× 516 0.9× 187 0.4× 19 1.9k
Cindy Kunne Netherlands 25 889 0.9× 513 0.7× 339 0.5× 719 1.2× 141 0.3× 35 1.7k
Wei‐Dong Chen China 20 741 0.8× 829 1.1× 525 0.8× 409 0.7× 307 0.7× 41 1.9k
Donna Yu United States 16 858 0.9× 546 0.7× 575 0.8× 525 0.9× 286 0.7× 18 1.6k
B Lombardi United States 28 402 0.4× 702 0.9× 490 0.7× 616 1.0× 212 0.5× 66 2.3k
S. Saccomanno Italy 22 266 0.3× 697 0.9× 1.3k 1.9× 615 1.0× 838 1.9× 42 2.4k

Countries citing papers authored by Philip B. Hylemon

Since Specialization
Citations

This map shows the geographic impact of Philip B. Hylemon's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Philip B. Hylemon with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Philip B. Hylemon more than expected).

Fields of papers citing papers by Philip B. Hylemon

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Philip B. Hylemon. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Philip B. Hylemon. The network helps show where Philip B. Hylemon may publish in the future.

Co-authorship network of co-authors of Philip B. Hylemon

This figure shows the co-authorship network connecting the top 25 collaborators of Philip B. Hylemon. A scholar is included among the top collaborators of Philip B. Hylemon based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Philip B. Hylemon. Philip B. Hylemon is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Robertson, Chadia L., Jyoti Srivastava, Ayesha Siddiq, et al.. (2015). Astrocyte Elevated Gene-1 (AEG-1) Regulates Lipid Homeostasis. Journal of Biological Chemistry. 290(29). 18227–18236. 19 indexed citations
2.
Bajaj, Jasmohan S., Patrick M. Gillevet, Neeral R. Patel, et al.. (2012). A longitudinal systems biology analysis of lactulose withdrawal in hepatic encephalopathy. Metabolic Brain Disease. 27(2). 205–215. 76 indexed citations
3.
Park, Margaret A., Guo Zhang, Aditi Pandya Martin, et al.. (2008). Vorinostat and sorafenib increase ER stress, autophagy and apoptosis via ceramide-dependent CD95 and PERK activation. Cancer Biology & Therapy. 7(10). 1648–1662. 146 indexed citations
4.
Park, Margaret A., Guo Zhang, James N. Norris, et al.. (2008). Regulation of autophagy by ceramide-CD95-PERK signaling. Autophagy. 4(7). 929–931. 28 indexed citations
5.
Fang, Youwen, Elaine Studer, Clint Mitchell, et al.. (2007). Conjugated Bile Acids Regulate Hepatocyte Glycogen Synthase Activity In Vitro and In Vivo via Gαi Signaling. Molecular Pharmacology. 71(4). 1122–1128. 40 indexed citations
6.
Dent, Paul, Youwen Fang, Seema Gupta, et al.. (2005). Conjugated bile acids promote ERK1/2 and AKT activation via a pertussis toxin–sensitive mechanism in murine and human hepatocytes†. Hepatology. 42(6). 1291–1299. 100 indexed citations
7.
Han, Song Iy, Elaine Studer, Seema Gupta, et al.. (2004). Bile acids enhance the activity of the insulin receptor and glycogen synthase in primary rodent hepatocytes. Hepatology. 39(2). 456–463. 52 indexed citations
8.
Qiao, Liang, Youwen Fang, Donna Gilfor, et al.. (2003). Regulation of p21 and p27 expression by the hepatitis B virus X protein and the alternate initiation site X proteins, AUG2 and AUG3. Journal of Gastroenterology and Hepatology. 18(4). 376–385. 11 indexed citations
9.
Lombard, Catherine, Robert J. McKallip, Philip B. Hylemon, & Prakash Nagarkatti. (2003). Fas Ligand-dependent and -independent mechanisms of toxicity induced by T cell lymphomas in lymphoid organs and in the liver. Clinical Immunology. 109(2). 144–153. 6 indexed citations
10.
Qiao, Liang, Robert McKinstry, Seema Gupta, et al.. (2002). Cyclin kinase inhibitor p21 potentiates bile acid-induced apoptosis in hepatocytes that is dependent on p53. Hepatology. 36(1). 39–48. 40 indexed citations
11.
Qiao, Liang, Adly Yacoub, Elaine Studer, et al.. (2002). Inhibition of the MAPK and PI3K pathways enhances UDCA-induced apoptosis in primary rodent hepatocytes. Hepatology. 35(4). 779–789. 123 indexed citations
12.
Qiao, Liang, Robert McKinstry, Donna Gilfor, et al.. (2001). Hepatitis B virus X protein increases expression of p21Cip-1/WAF1/MDA6 and p27Kip-1 in primary mouse hepatocytes, leading to reduced cell cycle progression. Hepatology. 34(5). 906–917. 52 indexed citations
13.
Park, Jong Sung, Liang Qiao, Donna Gilfor, et al.. (2000). A Role for Both Ets and C/EBP Transcription Factors and mRNA Stabilization in the MAPK-dependent Increase in p21Cip-1/WAF1/mda6Protein Levels in Primary Hepatocytes. Molecular Biology of the Cell. 11(9). 2915–2932. 68 indexed citations
14.
Jarvis, W. David, Kelly L. Auer, Mark S. Spector, et al.. (1997). Positive and negative regulation of JNK1 by protein kinase C and p42MAP kinase in adult rat hepatocytes. FEBS Letters. 412(1). 9–14. 30 indexed citations
15.
Ghosh, Shobha, Darrell H. Mallonee, Philip B. Hylemon, & William Grogan. (1995). Molecular cloning and expression of rat hepatic neutral cholesteryl ester hydrolase. Biochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism. 1259(3). 305–312. 55 indexed citations
16.
Heuman, Douglas M., et al.. (1991). Conjugates of ursodeoxycholate protect against cholestasis and hepatocellular necrosis caused by more hydrophobic bile salts. Gastroenterology. 100(1). 203–211. 204 indexed citations
18.
Lalwani, Narendra D., Philip B. Hylemon, & Stephen C. Strom. (1991). Altered levels of phosphoinositide metabolites and activation of guanine‐nucleotide dependent phospholipase C in rat hepatic tumors. Journal of Cellular Physiology. 147(2). 354–361. 11 indexed citations
19.
Hylemon, Philip B., et al.. (1990). Cholesterol and Bile Acid Metabolism in Cultures of Primary Rat Bile Ductular Epithelial Cells. Hepatology. 11(6). 982–988. 14 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026